MetaCap

Liquidia Cash Flow Statement

NASDAQ: LQDAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

27.38-0.64 (-2.28%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Liquidia free cash flow

In fiscal 2025, Liquidia generated -$35.7 million of operating cash flow and spent $4.3 million on capital expenditures. That left free cash flow of -$40.0 million, a free-cash-flow margin of -25.3% of revenue.

Summary generated from market data by MetaCap's automated system. Methodology

Liquidia cash flow statement (annual)

Liquidia annual cash flow statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31FY 20192019-12-31
Net Income-68.92M-128.29M-78.50M-41.02M-34.58M-59.76M-47.58M
Net Income growth (YoY)———————
Depreciation & Amortization1.53M2.20M2.18M3.65M5.61M3.13M2.57M
Stock-Based Compensation29.47M18.81M10.09M9.30M6.75M3.95M3.38M
Change in Working Capital-76.11M1.55M-994.00K-1.93M-10.59M-429.17K-7.88M
Operating Cash Flow-35.69M-93.42M-41.56M-28.59M-34.03M-54.14M-48.28M
Capital Expenditures-4.34M-4.95M-1.29M-592.00K-107.00K-752.09K-1.85M
Investing Cash Flow-6.34M-8.44M-11.29M-587.00K-107.00K247.91K-1.85M
Debt Issued74.97M57.46M41.74M19.77M10.41M05.00M
Debt Repaid-21.09M-4.85M-21.65M-10.50M-10.35M-5.65M0
Financing Cash Flow59.73M194.66M43.25M64.96M26.32M63.42M66.39M
Net Change in Cash17.70M92.80M-9.60M35.79M-7.82M9.52M16.26M
Free Cash Flow-40.02M-98.37M-42.85M-29.18M-34.14M-54.90M-50.13M

This table shows 7 annual periods of Liquidia's cash flow statement, from FY 2025 back to FY 2019, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow LQDA's reporting calendar. What is a cash flow statement?

More financial data